Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017
Progressive supranuclear palsy (PSP) belongs to the disease spectrum of Parkinsonian syndromes. Due to the chronic and progressive neurodegenerative course of the disease, PSP patients often have to be hospitalized to undergo diagnostic and therapeutic measures. The dynamics and characteristics of P...
Main Authors: | Maria Angela Samis Zella, Dirk Bartig, Lennard Herrmann, Gesine Respondek, Günter Höglinger, Ralf Gold, Dirk Woitalla, Christos Krogias, Lars Tönges |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/8/2454 |
Similar Items
-
Clinical Phenotypes of Progressive Supranuclear Palsy—The Differences in Interleukin Patterns
by: Natalia Madetko-Alster, et al.
Published: (2023-10-01) -
Potential of Non-Coding RNA as Biomarkers for Progressive Supranuclear Palsy
by: Fabio A. Simoes, et al.
Published: (2022-11-01) -
The Burden of Progressive Supranuclear Palsy on Patients, Caregivers, and Healthcare Systems by PSP Phenotype: A Cross-Sectional Study
by: Demetris Pillas, et al.
Published: (2022-07-01) -
The "hummingbird" lady: A case report on progressive supranuclear palsy
by: Mosam V Phirke, et al.
Published: (2015-01-01) -
The Assessment of Subregions in the Frontal Lobe May Be Feasible in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA)
by: Piotr Alster, et al.
Published: (2022-10-01)